In the complex landscape of pharmaceutical development, understanding the properties and applications of key chemical intermediates is crucial for success. 3-Bromo-1-adamantanecarboxylic acid, identified by CAS number 21816-08-0, is one such compound that plays a significant role as a pharmaceutical intermediate. As a leading manufacturer and supplier in China, we aim to provide clarity on this vital molecule and its importance in the industry.

The compound features a rigid adamantane cage structure, with a bromine atom attached at the 3-position and a carboxylic acid group at the 1-position. This unique combination imparts specific reactivity and structural characteristics that are highly valued in organic synthesis, particularly for creating advanced pharmaceutical ingredients. Its typical appearance is a light yellow powder, with a melting point around 147-148°C and a purity of ≥98%, ensuring its suitability for demanding applications.

The significance of 3-Bromo-1-adamantanecarboxylic acid is most evident in its application for synthesizing novel adamantyl derivatives. These derivatives are being explored for their potential as multidrug resistance (MDR) reversal agents, which are critical in enhancing the efficacy of cancer chemotherapy. By enabling the development of compounds that overcome drug resistance, this intermediate contributes directly to advancing cancer treatment strategies.

For research institutions and pharmaceutical companies looking to procure this essential intermediate, understanding the market is key. We offer 3-bromo-1-adamantanecarboxylic acid with competitive pricing and a commitment to high quality. We encourage you to reach out for a quote to learn more about how our reliable supply and technical expertise can support your drug discovery and development programs. As your trusted chemical manufacturer, we are dedicated to facilitating your scientific advancements.